$ZYME Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zymeworks Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Zymeworks Inc.. Get notifications about new insider transactions in Zymeworks Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | ZYME | Zymeworks Inc. | Neu Kelvin | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| May 07 2021 | ZYME | Zymeworks Inc. | Hillan Kenneth J. | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| May 07 2021 | ZYME | Zymeworks Inc. | Mahony Susan | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| May 07 2021 | ZYME | Zymeworks Inc. | Sacks Natalie | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| May 07 2021 | ZYME | Zymeworks Inc. | Cox Troy | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| May 07 2021 | ZYME | Zymeworks Inc. | RENTON HOLLINGS | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| May 07 2021 | ZYME | Zymeworks Inc. | Zoth Lota S. | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
| Apr 13 2021 | ZYME | Zymeworks Inc. | Priour James | Chief Commercial Of ... | Option Exercise | M | 0.00 | 2,266 | 0 | 4,534 | |
| Apr 13 2021 | ZYME | Zymeworks Inc. | Priour James | Chief Commercial Of ... | Sell | S | 27.93 | 950 | 26,533 | 2,003 | 3 K to 2 K (-32.17 %) |
| Apr 13 2021 | ZYME | Zymeworks Inc. | Priour James | Chief Commercial Of ... | Buy | M | 0.00 | 2,266 | 0 | 2,953 | 687 to 3 K (+329.84 %) |
| Mar 17 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | M | 34.24 | 837 | 28,659 | 94,160 | |
| Mar 17 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Buy | M | 34.24 | 837 | 28,659 | 5,840 | 5 K to 5.8 K (+16.73 %) |
| Mar 17 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Sell | S | 34.72 | 786 | 27,290 | 5,003 | 5.8 K to 5 K (-13.58 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | A | 34.82 | 30,000 | 1,044,600 | 30,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | M | 0.00 | 1,354 | 0 | 2,709 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Sell | S | 34.95 | 568 | 19,854 | 5,789 | 6.4 K to 5.8 K (-8.94 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Buy | M | 0.00 | 1,354 | 0 | 6,357 | 5 K to 6.4 K (+27.06 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Priour James | Chief Commercial Of ... | Option Exercise | A | 0.00 | 6,250 | 0 | 6,250 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Priour James | Chief Commercial Of ... | Option Exercise | A | 34.82 | 37,500 | 1,305,750 | 37,500 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 34.82 | 48,750 | 1,697,475 | 48,750 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Sell | S | 34.95 | 1,048 | 36,631 | 30,979 | 32 K to 31 K (-3.27 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Buy | M | 0.00 | 2,500 | 0 | 32,027 | 29.5 K to 32 K (+8.47 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | A | 34.82 | 150,000 | 5,223,000 | 150,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | M | 0.00 | 7,708 | 0 | 15,417 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Sell | S | 34.95 | 4,392 | 153,516 | 260,325 | 264.7 K to 260.3 K (-1.66 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Buy | M | 0.00 | 7,708 | 0 | 264,717 | 257 K to 264.7 K (+3.00 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | A | 34.82 | 48,750 | 1,697,475 | 48,750 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Sell | S | 34.95 | 1,048 | 36,631 | 5,377 | 6.4 K to 5.4 K (-16.31 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Buy | M | 0.00 | 2,500 | 0 | 6,425 | 3.9 K to 6.4 K (+63.69 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | A | 34.82 | 48,750 | 1,697,475 | 48,750 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Sell | S | 34.95 | 1,425 | 49,809 | 10,471 | 11.9 K to 10.5 K (-11.98 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Buy | M | 0.00 | 2,500 | 0 | 11,896 | 9.4 K to 11.9 K (+26.61 %) |
| Feb 16 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | M | 34.24 | 2,083 | 71,322 | 94,997 | |
| Feb 16 2021 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Buy | M | 34.24 | 2,083 | 71,322 | 5,003 | 2.9 K to 5 K (+71.34 %) |
| Jan 11 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 30.92 | 48 | 1,484 | 29,527 | 29.5 K to 29.5 K (+0.16 %) |
| Jan 11 2021 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Grant | A | 30.92 | 284 | 8,781 | 9,406 | 9.1 K to 9.4 K (+3.11 %) |
| Jan 11 2021 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Grant | A | 30.92 | 207 | 6,400 | 3,925 | 3.7 K to 3.9 K (+5.57 %) |
| Dec 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | M | 5.67 | 16,620 | 94,249 | 4,330 | |
| Dec 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | M | 4.19 | 8,380 | 35,150 | 0 | |
| Dec 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Sell | S | 53.25 | 25,000 | 1,331,133 | 9,122 | 34.1 K to 9.1 K (-73.27 %) |
| Dec 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Buy | M | 5.67 | 16,620 | 94,249 | 34,122 | 17.5 K to 34.1 K (+94.96 %) |
| Dec 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Buy | M | 4.19 | 8,380 | 35,150 | 17,502 | 9.1 K to 17.5 K (+91.87 %) |
| Dec 09 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Sell | S | 56.16 | 850 | 47,736 | 55,511 | 56.4 K to 55.5 K (-1.51 %) |
| Nov 19 2020 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | M | 34.24 | 2,920 | 99,981 | 97,080 | |
| Nov 19 2020 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Buy | M | 34.24 | 2,920 | 99,981 | 2,920 | 0 to 2.9 K |
| Nov 04 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Sell | S | 39.04 | 3,500 | 136,624 | 56,361 | 59.9 K to 56.4 K (-5.85 %) |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | M | 11.84 | 10,000 | 118,400 | 65,000 | |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | M | 9.82 | 10,000 | 98,200 | 75,000 | |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | M | 17.15 | 10,000 | 171,500 | 17,235 | |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | M | 15.74 | 10,000 | 157,400 | 14,702 | |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Sell | S | 45.00 | 40,000 | 1,800,000 | 3,718 | 43.7 K to 3.7 K (-91.50 %) |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Buy | M | 11.84 | 10,000 | 118,400 | 43,718 | 33.7 K to 43.7 K (+29.66 %) |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Buy | M | 9.82 | 10,000 | 98,200 | 33,718 | 23.7 K to 33.7 K (+42.16 %) |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Buy | M | 17.15 | 10,000 | 171,500 | 23,718 | 13.7 K to 23.7 K (+72.90 %) |
| Sep 16 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Buy | M | 15.74 | 10,000 | 157,400 | 13,718 | 3.7 K to 13.7 K (+268.96 %) |
| Jul 06 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Grant | A | 30.66 | 367 | 11,252 | 3,718 | 3.4 K to 3.7 K (+10.95 %) |
| Jul 06 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 30.66 | 488 | 14,962 | 29,479 | 29 K to 29.5 K (+1.68 %) |
| Jul 06 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Grant | A | 30.66 | 277 | 8,493 | 9,112 | 8.8 K to 9.1 K (+3.14 %) |
| May 12 2020 | ZYME | Zymeworks Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 12 2020 | ZYME | Zymeworks Inc. | Sacks Natalie | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 12 2020 | ZYME | Zymeworks Inc. | Mahony Susan | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 12 2020 | ZYME | Zymeworks Inc. | Hillan Kenneth J. | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 12 2020 | ZYME | Zymeworks Inc. | Zoth Lota S. | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 12 2020 | ZYME | Zymeworks Inc. | Cox Troy | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 12 2020 | ZYME | Zymeworks Inc. | RENTON HOLLINGS | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| Apr 13 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | M | 3.85 | 1,000 | 3,854 | 57,660 | |
| Apr 13 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | M | 3.85 | 1,000 | 3,854 | 57,660 | |
| Apr 13 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Buy | M | 3.85 | 1,000 | 3,854 | 257,009 | 256 K to 257 K (+0.39 %) |
| Apr 13 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Buy | M | 3.85 | 1,000 | 3,854 | 257,009 | 256 K to 257 K (+0.39 %) |
| Apr 07 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Buy | P | 33.39 | 80 | 2,671 | 59,861 | 59.8 K to 59.9 K (+0.13 %) |
| Apr 07 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Buy | P | 33.39 | 495 | 16,528 | 59,781 | 59.3 K to 59.8 K (+0.83 %) |
| Mar 16 2020 | ZYME | Zymeworks Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 24.28 | 18,000 | 437,040 | 18,000 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 35.20 | 45,000 | 1,584,000 | 45,000 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | A | 35.20 | 45,000 | 1,584,000 | 45,000 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | A | 35.20 | 45,000 | 1,584,000 | 45,000 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | A | 0.00 | 23,125 | 0 | 23,125 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | A | 35.20 | 138,750 | 4,884,000 | 138,750 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | A | 0.00 | 4,063 | 0 | 4,063 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | A | 35.20 | 24,375 | 858,000 | 24,375 | |
| Jan 28 2020 | ZYME | Zymeworks Inc. | Cox Troy | Director | Buy | P | 46.50 | 7,500 | 348,750 | 7,500 | 0 to 7.5 K |
| Jan 09 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 19.54 | 371 | 7,249 | 28,991 | 28.6 K to 29 K (+1.30 %) |
| Jan 09 2020 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Grant | A | 19.54 | 332 | 6,487 | 3,351 | 3 K to 3.4 K (+11.00 %) |
| Jan 09 2020 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Grant | A | 19.54 | 394 | 7,699 | 8,835 | 8.4 K to 8.8 K (+4.67 %) |
| Dec 13 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | M | 15.00 | 27,500 | 412,500 | 82,500 | |
| Dec 13 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Buy | M | 15.00 | 27,500 | 412,500 | 28,620 | 1.1 K to 28.6 K (+2,455.36 %) |
| Nov 08 2019 | ZYME | Zymeworks Inc. | O'Driscoll Kathryn | Chief People Office ... | Option Exercise | A | 34.24 | 100,000 | 3,424,000 | 100,000 | |
| Jul 10 2019 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Grant | A | 12.49 | 520 | 6,495 | 3,019 | 2.5 K to 3 K (+20.81 %) |
| Jul 10 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 12.49 | 1,120 | 13,989 | 1,120 | 0 to 1.1 K |
| Jul 10 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Grant | A | 12.49 | 464 | 5,795 | 8,441 | 8 K to 8.4 K (+5.82 %) |
| May 08 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | M | 3.53 | 8,380 | 29,581 | 0 | |
| May 08 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | M | 2.66 | 6,704 | 17,833 | 0 | |
| May 08 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Sell | S | 19.25 | 1,604 | 30,878 | 7,977 | 9.6 K to 8 K (-16.74 %) |
| May 08 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Buy | M | 3.53 | 8,380 | 29,581 | 9,581 | 1.2 K to 9.6 K (+697.75 %) |
| May 08 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Sell | S | 19.22 | 6,704 | 128,855 | 1,201 | 7.9 K to 1.2 K (-84.81 %) |
| May 08 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Buy | M | 2.66 | 6,704 | 17,833 | 7,905 | 1.2 K to 7.9 K (+558.20 %) |
| May 08 2019 | ZYME | Zymeworks Inc. | Sacks Natalie | Director | Option Exercise | A | 19.11 | 10,000 | 191,100 | 10,000 | |
| May 08 2019 | ZYME | Zymeworks Inc. | Hillan Kenneth J. | Director | Option Exercise | A | 19.11 | 10,000 | 191,100 | 10,000 | |
| May 08 2019 | ZYME | Zymeworks Inc. | Zoth Lota S. | Director | Option Exercise | A | 19.11 | 10,000 | 191,100 | 10,000 | |
| May 08 2019 | ZYME | Zymeworks Inc. | RENTON HOLLINGS | Director | Option Exercise | A | 19.11 | 10,000 | 191,100 | 10,000 | |
| May 08 2019 | ZYME | Zymeworks Inc. | Bedford Nick | Director | Option Exercise | A | 19.11 | 10,000 | 191,100 | 10,000 | |
| Mar 29 2019 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Sell | S | 16.24 | 3,000 | 48,720 | 59,286 | 62.3 K to 59.3 K (-4.82 %) |
| Mar 28 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | A | 15.23 | 15,000 | 228,450 | 15,000 | |
| Feb 04 2019 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 16.00 | 250,000 | 4,000,000 | 2,898,647 | 3.1 M to 2.9 M (-7.94 %) |
| Jan 10 2019 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Option Exercise | A | 15.53 | 75,000 | 1,164,750 | 75,000 | |
| Jan 10 2019 | ZYME | Zymeworks Inc. | HAUSMAN DIANA | Chief Medical Offic ... | Grant | A | 12.48 | 499 | 6,228 | 2,499 | 2 K to 2.5 K (+24.95 %) |
| Jan 10 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Option Exercise | A | 15.53 | 90,000 | 1,397,700 | 90,000 | |
| Jan 10 2019 | ZYME | Zymeworks Inc. | Klompas Neil A | Chief Financial Off ... | Grant | A | 12.48 | 414 | 5,167 | 1,201 | 787 to 1.2 K (+52.60 %) |
| Jan 10 2019 | ZYME | Zymeworks Inc. | Tehrani Ali | Chief Executive Off ... | Option Exercise | A | 15.53 | 235,000 | 3,649,550 | 235,000 | |
| Jan 10 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 15.53 | 75,000 | 1,164,750 | 75,000 | |
| Jan 10 2019 | ZYME | Zymeworks Inc. | Poon David Kai Yuen | See Remarks | Option Exercise | A | 15.53 | 25,000 | 388,250 | 25,000 | |
| Nov 08 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.00 | 700,000 | 9,800,000 | 3,148,647 | 3.8 M to 3.1 M (-18.19 %) |
| Sep 26 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 16.36 | 2,027 | 33,162 | 3,848,647 | 3.9 M to 3.8 M (-0.05 %) |
| Sep 20 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.56 | 6,870 | 100,027 | 3,850,674 | 3.9 M to 3.9 M (-0.18 %) |
| Sep 18 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.58 | 6,865 | 100,092 | 3,857,544 | 3.9 M to 3.9 M (-0.18 %) |
| Sep 18 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.58 | 9,009 | 131,351 | 3,864,409 | 3.9 M to 3.9 M (-0.23 %) |
| Sep 14 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.32 | 20,900 | 299,288 | 3,873,418 | 3.9 M to 3.9 M (-0.54 %) |
| Sep 14 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.83 | 10,059 | 149,175 | 3,894,318 | 3.9 M to 3.9 M (-0.26 %) |
| Sep 12 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.87 | 11,277 | 167,689 | 3,904,377 | 3.9 M to 3.9 M (-0.29 %) |
| Sep 12 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.44 | 4,500 | 64,980 | 3,915,654 | 3.9 M to 3.9 M (-0.11 %) |
| Sep 04 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.26 | 700 | 9,982 | 3,920,154 | 3.9 M to 3.9 M (-0.02 %) |
| Sep 04 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.26 | 700 | 9,982 | 3,920,154 | 3.9 M to 3.9 M (-0.02 %) |
| Aug 31 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.35 | 3,440 | 49,364 | 3,920,854 | 3.9 M to 3.9 M (-0.09 %) |
| Aug 31 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.26 | 2,312 | 32,969 | 3,924,294 | 3.9 M to 3.9 M (-0.06 %) |
| Aug 16 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.28 | 3,000 | 42,840 | 3,926,606 | 3.9 M to 3.9 M (-0.08 %) |
| Aug 14 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.33 | 4,531 | 64,929 | 3,929,606 | 3.9 M to 3.9 M (-0.12 %) |
| Aug 14 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 14.28 | 1,898 | 27,103 | 3,934,137 | 3.9 M to 3.9 M (-0.05 %) |
| Aug 07 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 13.55 | 1,650 | 22,358 | 3,936,035 | 3.9 M to 3.9 M (-0.04 %) |
| Aug 03 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 13.31 | 19,400 | 258,214 | 3,937,685 | 4 M to 3.9 M (-0.49 %) |
| Aug 03 2018 | ZYME | Zymeworks Inc. | LILLY ELI & CO | 10% Owner | Sell | S | 13.31 | 19,400 | 258,214 | 3,937,685 | 4 M to 3.9 M (-0.49 %) |
Page: 1